People
17 January 2019 - Biopharmaceutical company Protagonist Therapeutics Inc (Nasdaq:PTGX) on Wednesday announced the grant of stock options to newly appointed executive vice president of clinical operati...
16 January 2019 - - US-based clinical stage biotechnology company ImmunSYS has added Douglas G. Watson to its board of directors as lead independent director, the company said.

Watson is ...
16 January 2019 - - US-based ArunA Bio, a specialist in the development of exosomes for the treatment of CNS and neurodegenerative disorders, has appointed Mark Sirgo, Pharm.D. as chief executive offi...
16 January 2019 - - UK-based biotechnology company Phico Therapeutics Ltd has appointed Andrew Armour as financial director, and professor Mark Wilcox and David Beadle as non-executive directors, the ...
16 January 2019 - - US-based microbiome therapeutics platform company Seres Therapeutics, Inc. (NASDAQ: MCRB) has appointed Eric D. Shaff as president and chief executive officer, the company said.
16 January 2019 - - UK-based T Cell Receptor biotechnology company Immunocore Ltd has named David Berman as its new head of research and development, the company said.

David joined Immuno...